PG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Term ID

CHEBI:89332

Synonyms

1-(6Z,9Z,12Z-Octadecatrienoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-glycerol)
1-g-Linolenoyl-2-linoleoyl-sn-glycero-3-phosphoglycerol
1-gamma-Linolenoyl-2-linoleoyl-sn-glycero-3-phosphoglycerol
[(2S)-2,3-dihydroxypropoxy][(2R)-3-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy]phosphinic acid
GPG(18:3/18:2)
GPG(18:3n6/18:2n6)
GPG(18:3w6/18:2w6)
GPG(36:5)
PG(18:3/18:2)
PG(18:3n6/18:2n6)
PG(18:3w6/18:2w6)
PG(36:5)
Phosphatidylglycerol(18:3/18:2)
Phosphatidylglycerol(18:3n6/18:2n6)
Phosphatidylglycerol(18:3w6/18:2w6)
Phosphatidylglycerol(36:5)

(all 16)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Phenotype where environments contain PG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Phenotype modified by environments containing PG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Phenotype affecting PG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Human Disease Model